Ambarella Inc vs Johnson & Johnson — how do they compare? Ambarella Inc trades at $83.82 (market cap $3.64B), while Johnson & Johnson trades at $258 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 172× Ambarella Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Ambarella Inc pays none. Which is the better fit depends on your goals.
| AMBA | JNJ | |
|---|---|---|
Market Cap | $3.64B | $626.09B |
Sector | Technology | Health |
52-Week High | $95.51 | $267.24 |
52-Week Low | $48.65 | $172.78 |
Enterprise Value | $3.37B | $654.37B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.06% |
Trailing returns across standard periods
Latest headlines on both assets
Ambarella is a semiconductor company specializing in low-power video compression and computer vision processors. Its chips power AI cameras for security, automotive safety, and robotics applications.
Read more on AMBA →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →